Reports
Sale
Global Heparin Market Size, Share, Report: By Type: Low Molecular weight Heparin, Ultra-Low Molecular weight Heparin, Unfractionated Heparin; By Application: Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Others; By Mode of Administration; By End User; By Source; Regional Analysis; Supplier Landscape; 2023-2031
Global Heparin Market Outlook
The global heparin market value was USD 8.70 million in 2022, driven by the increasing demand for high spending on health care and patient awareness across the globe. The market size is anticipated to grow at a CAGR of 4.4% during the forecast period of 2023-2031 to achieve a value of USD 12.80 million by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Heparin prevents blood clot formation within the blood vessels and is used to treat heart conditions and unstable angina. It is also used in post-surgery, dialysis, and transfusion of blood. Heparin is usually injected into the muscle or veins directly to break up clots and maintain smooth blood fluidity.
Global Heparin Market: Properties and Applications
The heparin market can be divided based on segments like types, applications, route of administration, and end-uses.
The heparin market can be divided based on its types as low molecular weight heparin, ultra-low molecular weight heparin, and unfractionated heparin. They all are further subdivided into intravenous and subcutaneous.
The heparin industry can be divided based on its application sectors as:
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The heparin industry is classified based on its route of administration into:
- Intravenous
- Subcutaneous
The heparin industry can be bifurcated based on its end-use as outpatient and inpatient.
The EMR report looks into the regional heparin markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Global Heparin Market Analysis
It is expected that the increased incidences of venous thromboembolism and cardiovascular disorders will fuel the heparin market growth over the forecast period. Roughly 900,250 people in the United States are affected by deep vein thrombosis and pulmonary embolism every year, according to data published by the Center for Disease Control and Prevention (CDC) in 2018. This factor is projected in the coming years to boost the regional demand for heparin. The high demand for anticoagulants is also expected to boost the overall heparin industry. In addition, high spending on health care and patient awareness are some of the key factors expected to accelerate the heparin market growth over the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Heparin Market: Competitive Landscape
The report presents a detailed analysis of the following key players in the global heparin market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- GlaxoSmithKline plc (GSK)
- Pfizer Inc. [NYSE: PFE]
- LeoPharma A/S
- Sanofi
- Dr. Reddy’s Laboratories Ltd.
- Aspen Pharmacare Holdings Limited
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Others
The EMR report gives an in-depth insight into the heparin market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by Mode of Administration |
|
| Breakup by End User |
|
| Breakup by Source |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Heparin Market Overview
3.1 Global Heparin Market Historical Value (2016-2022)
3.2 Global Heparin Market Forecast Value (2023-2031)
4 Global Heparin Market Landscape
4.1 Global Heparin Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Heparin Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by End User
4.2.3 Analysis by Applications
5 Global Heparin Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Heparin Market Segmentation
6.1 Global Heparin Market by Type
6.1.1 Market Overview
6.1.2 Low Molecular weight Heparin
6.1.2.1 Intravenous
6.1.2.2 Subcutaneous
6.1.3 Ultra-Low Molecular weight Heparin
6.1.3.1 Intravenous
6.1.3.2 Subcutaneous
6.1.4 Unfractionated Heparin
6.1.4.1 Intravenous
6.1.4.2 Subcutaneous
6.2 Global Heparin Market by Application
6.2.1 Market Overview
6.2.2 Venous Thromboembolism
6.2.3 Atrial Fibrillation
6.2.4 Renal Impairment
6.2.5 Coronary Artery Disease
6.2.6 Others
6.3 Global Heparin Market by Mode of Administration
6.3.1 Market Overview
6.3.2 Intravenous
6.3.3 Subcutaneous
6.4 Global Heparin Market by End User
6.4.1 Market Overview
6.4.2 Outpatient
6.4.3 Inpatient
6.5 Global Heparin Market by Source
6.5.1 Market Overview
6.5.2 Porcine
6.5.3 Bovine
6.5.4 Others
6.6 Global Heparin Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Heparin Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Heparin Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Heparin Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Heparin Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Heparin Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 GlaxoSmithKline plc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Pfizer Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Leo Pharma A/S
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Sanofi S.A
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Dr. Reddy’s Laboratories Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Aspen Pharmacare Holdings Limited
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 B. Braun Melsungen AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Fresenius Kabi AG
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Sandoz (Novartis AG)
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Teva Pharmaceuticals
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Viatris Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Heparin Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The heparin Market was valued at USD 8.70 million in 2022.
The market is expected to grow at a CAGR of 4.4% from 2023 to 2031 to reach USD a value of USD 12.8 billion by 2031.
The major drivers of the industry include increased incidences of venous thromboembolism and cardiovascular disorders, high spending on health care and patient awareness.
The high demand for anticoagulants is expected to be a key trend guiding the growth of the industry.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The types of the product include low molecular weight heparin, ultra-low molecular weight heparin, and unfractionated heparin.
Heparin finds applications in venous thromboembolism, atrial fibrillation, renal impairment, and coronary artery disease, amongst others.
Heparin can have different end-uses like intravenous and subcutaneous.
The end-uses can be divided into outpatient and inpatient.
The leading players in this market are GlaxoSmithKline plc (GSK) [GSK (LON)], Pfizer Inc. [PFE (NYSE)], LeoPharma A/S, Sanofi [SAN (EPA)], Dr. Reddy’s Laboratories Ltd. [DRREDDY (NSE)], Aspen Pharmacare Holdings Limited, B. Braun Melsungen AG, Fresenius Kabi AG, Others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999$5999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER